glp-1 cardiovascular news More news: in a late-stage study in type 2 diabetes and elevated risk, our new GLP-1 pill showed cardiovascular safety. Read more: https://e.lilly/4myJlm8 Glucagon-like peptide 1 receptor agonists:

and Kindness

Discover the gut bacteria that naturally boost GLP-1

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Does GLP-1 give you heartburn

Much hyped online, FDA-approved diabetes wonder drugs, now touted for treating obesity

Discover evidence-based guidance on optimal timing for semaglutide, dulaglutide, and other GLP-1 medications, including NHS recommendations and side effect management strategies.